1AFX Stock Financial Analysis - Carl Zeiss Meditec AG (BIT) Stock

Overview

Carl Zeiss Meditec AG, based in Germany, operates predominantly in the healthcare technology sector, focusing specifically on medical optics and devices. The company plays a crucial role in advancing ophthalmic diagnostics and therapeutic solutions, along with developing innovative technologies for microsurgery that significantly enhance clinical outcomes and streamline workflow in healthcare environments. Key projects include advanced imaging systems for eye examinations, laser and surgical devices for vision correction, and visualization solutions for microsurgery, using cutting-edge optical technologies. Carl Zeiss Meditec's commitment to high-quality medical solutions promotes its stance as a leader in precision medicine, contributing robustly to global healthcare advancements.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Carl Zeiss Meditec AG as of June 30, 2025 is 2,179.73 MM.
The operating income for Carl Zeiss Meditec AG as of June 30, 2025 is 176.91 MM.
The net income for Carl Zeiss Meditec AG as of June 30, 2025 is 150.13 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	2,179.73	176.91	150.13
2025-03-31	2,169.43	177.87	155.88
2024-12-31	2,081.63	171.61	157.03
2024-09-30	2,066.13	187.41	178.73
2024-06-30	2,066.20	271.27	203.20
2024-03-31	2,061.98	313.35	261.22
2023-12-31	2,094.00	331.16	276.80
2023-09-30	2,089.30	349.06	290.40
2023-06-30	2,079.54	368.98	307.91
2023-03-31	2,021.91	365.01	278.29
2022-12-31	1,962.94	385.08	307.01
2022-09-30	1,902.84	397.68	293.91
2022-06-30	1,781.48	363.88	245.28
2022-03-31	1,734.82	387.61	264.33
2021-12-31	1,688.09	371.48	227.88
2021-09-30	1,646.79	370.38	236.28
2021-06-30	1,565.75	347.83	235.38
2021-03-31	1,387.89	234.62	159.09
2020-12-31	1,334.65	193.43	129.88
2020-09-30	1,335.45	176.93	122.39

Income Statement: EPS

The earnings per share basic for Carl Zeiss Meditec AG as of June 30, 2025 is 1.71.
The earnings per share diluted for Carl Zeiss Meditec AG as of June 30, 2025 is 1.71.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30	1.71	1.71
2025-03-31	1.77	1.77
2024-12-31	1.78	1.78
2024-09-30	2.01
2024-06-30	2.28	2.28
2024-03-31	2.93	2.93
2023-12-31	3.10	3.10
2023-09-30	3.25
2023-06-30	3.44	3.44
2023-03-31	3.11	3.11
2022-12-31	3.44	3.44
2022-09-30	3.29
2022-06-30	2.74	2.74
2022-03-31	2.96	2.96
2021-12-31	2.54	2.54
2021-09-30	2.64
2021-06-30	2.64	2.64
2021-03-31	1.78	1.78
2020-12-31	1.46	1.46
2020-09-30	1.37

Cash Flow: Operations, Investing, Financing

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30
2025-03-31	195.61	-442.80	259.46
2024-12-31
2024-09-30	247.32	-412.31	176.25
2024-06-30
2024-03-31	263.28	-156.58	-101.42
2023-12-31
2023-09-30	250.86	-110.98	-135.09
2023-06-30
2023-03-31	161.51	22.04	-178.94
2022-12-31
2022-09-30	188.20	-92.89	-94.24
2022-06-30
2022-03-31	285.27	-100.74	-183.53
2021-12-31
2021-09-30	362.66	-75.20	-285.89
2021-06-30
2021-03-31	289.68	-81.00	-214.34
2020-12-31
2020-09-30	178.53	-70.95	-122.96

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for Carl Zeiss Meditec AG as of June 30, 2025 is 31.18.
The p/book for Carl Zeiss Meditec AG as of June 30, 2025 is 2.33.
The p/tbv for Carl Zeiss Meditec AG as of June 30, 2025 is 12.53.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30	31.18	2.33	12.53
2025-03-31	24.70	1.84	9.92
2024-12-31	21.63	1.88	5.12
2024-09-30	21.63	1.88	5.12
2024-06-30	15.12	1.87	2.80
2024-03-31	14.21	1.81	2.27
2023-12-31	13.60	1.82	2.28
2023-09-30	12.82	2.00	2.97
2023-06-30	12.82	2.00	2.97
2023-03-31	14.26	2.01	2.98
2022-12-31	13.44	1.95	2.52
2022-09-30	13.44	1.95	2.52
2022-06-30	16.08	2.25	3.30
2022-03-31	15.01	2.26	3.32
2021-12-31	17.49	2.38	3.03
2021-09-30	16.72	2.35	3.01
2021-06-30	16.56	2.49	3.62
2021-03-31	24.71	2.52	3.65
2020-12-31	30.27	2.71	3.65
2020-09-30	32.27	2.72	3.67

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Carl Zeiss Meditec AG as of June 30, 2025 is 0.04.
The ebit (3y)/ev for Carl Zeiss Meditec AG as of June 30, 2025 is 0.06.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	0.04	0.06
2025-03-31	0.05	0.08
2024-12-31	0.06	0.08
2024-09-30	0.06	0.08
2024-06-30	0.09	0.10
2024-03-31	0.10	0.10
2023-12-31	0.10	0.10
2023-09-30	0.11	0.09
2023-06-30	0.11	0.09
2023-03-31	0.10	0.08
2022-12-31	0.10	0.08
2022-09-30	0.10	0.08
2022-06-30	0.09	0.07
2022-03-31	0.09	0.07
2021-12-31	0.08	0.06
2021-09-30	0.09	0.06
2021-06-30	0.09	0.06
2021-03-31	0.06	0.05
2020-12-31	0.05	0.05
2020-09-30	0.05	0.05

Management Effectiveness

The roa for Carl Zeiss Meditec AG as of June 30, 2025 is 0.05.
The roe for Carl Zeiss Meditec AG as of June 30, 2025 is 0.07.
The roic for Carl Zeiss Meditec AG as of June 30, 2025 is 0.06.
The croic for Carl Zeiss Meditec AG as of June 30, 2025 is 0.00.
The ocroic for Carl Zeiss Meditec AG as of June 30, 2025 is 0.07.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.05	0.07	0.06	0.00	0.07
2025-03-31	0.05	0.07	0.06	0.00	0.07
2024-12-31	0.06	0.08	0.07	0.00	0.09
2024-09-30	0.06	0.08	0.07	0.00	0.09
2024-06-30	0.10	0.13	0.12	0.00	0.12
2024-03-31	0.10	0.14	0.12	0.00	0.11
2023-12-31	0.10	0.14	0.12	0.00	0.11
2023-09-30	0.12	0.18	0.14	0.00	0.08
2023-06-30	0.12	0.18	0.14	0.00	0.08
2023-03-31	0.11	0.16	0.13	0.00	0.08
2022-12-31	0.12	0.18	0.14	0.00	0.09
2022-09-30	0.12	0.18	0.14	0.00	0.09
2022-06-30	0.11	0.16	0.13	0.00	0.15
2022-03-31	0.12	0.17	0.14	0.00	0.15
2021-12-31	0.11	0.16	0.13	0.00	0.20
2021-09-30	0.12	0.16	0.13	0.00	0.20
2021-06-30	0.11	0.16	0.14	-0.00	0.17
2021-03-31	0.08	0.11	0.09	-0.00	0.17
2020-12-31	0.06	0.09	0.09	-0.01	0.12
2020-09-30	0.06	0.09	0.08	-0.01	0.12

Gross Margins

The gross margin for Carl Zeiss Meditec AG as of June 30, 2025 is 0.52.
The net margin for Carl Zeiss Meditec AG as of June 30, 2025 is 0.07.
The operating margin for Carl Zeiss Meditec AG as of June 30, 2025 is 0.08.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.52	0.07	0.08
2025-03-31	0.52	0.07	0.08
2024-12-31	0.53	0.09	0.09
2024-09-30	0.53	0.09	0.09
2024-06-30	0.56	0.13	0.15
2024-03-31	0.57	0.13	0.16
2023-12-31	0.58	0.14	0.17
2023-09-30	0.58	0.15	0.18
2023-06-30	0.58	0.15	0.18
2023-03-31	0.58	0.14	0.18
2022-12-31	0.59	0.15	0.21
2022-09-30	0.59	0.15	0.21
2022-06-30	0.59	0.14	0.20
2022-03-31	0.59	0.15	0.22
2021-12-31	0.59	0.13	0.22
2021-09-30	0.59	0.14	0.22
2021-06-30	0.58	0.15	0.22
2021-03-31	0.57	0.11	0.17
2020-12-31	0.56	0.10	0.14
2020-09-30	0.56	0.09	0.13

CH:001055489
GB:0DHC	€41.72
DE:AFX	€41.38
MX:AFX N
US:CZMWF
GB:AFXD
AT:AFX
BG:AFX